Helicobacter Pylori Diagnostics Market Report 2025 (Global Edition)

Global Helicobacter Pylori Diagnostics Market Report 2025 Market Size Split by test type, by Method (Laboratory Based Test, Point of Care Test), by End User (Diagnostics Laboratories, Hospitals, Other...

Helicobacter Pylori Diagnostics Market Report Description

We have various report editions of Helicobacter Pylori Diagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Helicobacter Pylori Diagnostics Market Insights Video

Competitive Landscape of the Helicobacter Pylori Diagnostics Market

There are some major firms and developing businesses in the Helicobacter pylori (H. pylori) diagnostics market. Development, production, and distribution of several diagnostic equipment and technologies are the activities carried out by these companies. Technology breakthroughs, strategic alliances, mergers, acquisitions, and new product introductions all contribute to the market's competitiveness and change.

May 2022: Helicobacter pylori can be found with the hp+detect diagnostic test, which was recently awarded the CE Mark by Biomerica, Inc. After the product is registered in each country where it is sold, the company will start to market and sell its HP+detect diagnostic test in the EU and other foreign markets. (Source: https://investors.biomerica.com/news/news-details/2022/Biomerica-Announces-CE-Mark-for-ItsH.-pylori-Diagnostic-Test-hpdetect/default.aspx)

Top Companies Market Share in Helicobacter Pylori Diagnostics Industry: (In no particular order of Rank)

• Meridian Bioscience
• Biohit Oyj
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Alpha Laboratories Ltd
• F. Hoffmann-La Roche Ltd
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Helicobacter Pylori Diagnostics Market

Which Region Dominates the Helicobacter Pylori Diagnostics Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. The increasing frequency of gastrointestinal illnesses and the accessibility of diagnostic facilities have created a sizable and growing market for H. pylori diagnostics in North America.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Helicobacter Pylori Diagnostics market. The market growth in the region is attributed to the growing prevalence of gastric disorder, the rising geriatric population and the growing investment in healthcare infrastructure.

 

The current report Scope analyzes Helicobacter Pylori Diagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Helicobacter Pylori Diagnostics Market Analysis

According to Cognitive Market Research, the global Helicobacter Pylori Diagnostics market size was estimated at USD 591.5 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 236.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Helicobacter Pylori Diagnostics market with a market size of USD 186.68 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. The demand is amplified by the nation's rising technological innovation.
• The Canada Helicobacter Pylori Diagnostics market had a market share of USD 28.39 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Canada's growing investment.
• The Mexico Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 21.53 million in 2024.

Europe Helicobacter Pylori Diagnostics Market Analysis

According to Cognitive Market Research, the global Helicobacter Pylori Diagnostics market size was estimated at USD 591.5 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 177.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.

• The United Kingdom Helicobacter Pylori Diagnostics market had a market share of USD 29.81 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. In the UK, Helicobacter Pylori Diagnostics sales witness an upswing due to the rising prevalence of infectious diseases.
• The France Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 16.33 million in 2024.
• According to Cognitive Market Research, the Germany Helicobacter Pylori Diagnostics market size was valued at USD 35.14 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. In Germany, Helicobacter Pylori Diagnostics sales surged due to the increasing investment.
• The Italy Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 15.26 million in 2024.
• The Russia Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 27.50 million in 2024.
• The Spain Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 4.1% during the forecast period with a market size of USD 14.55 million in 2024
• The Luxembourg Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 5.50 million in 2024.
• The Portugal Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 3.73 million in 2024.
• The Greece Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 2.13 million in 2024.
• Rest of Europe's Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 27.50 million in 2024.

Asia Pacific Helicobacter Pylori Diagnostics Market Analysis

According to Cognitive Market Research, the global Helicobacter Pylori Diagnostics market size was estimated at USD 591.5 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 136.05 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Helicobacter Pylori Diagnostics market size was valued at USD 61.22 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Helicobacter Pylori Diagnostics sales surged in China due to increasing advancements in technology.
• The Japan Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 18.77 million in 2024.
• The India Helicobacter Pylori Diagnostics market had a market share of USD 16.33 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. India's growing geriatric population drives the market growth.
• The South Korea Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 13.60 million in 2024.
• The Australia Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 7.07 million in 2024.
• The South East Asia Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 9.39 million in 2024.
• The Rest of the Asia Pacific Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 9.66 million in 2024.

South America Helicobacter Pylori Diagnostics Market Analysis

According to Cognitive Market Research, the global Helicobacter Pylori Diagnostics market size was estimated at USD 591.5 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 29.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Helicobacter Pylori Diagnostics market size was valued at USD 12.66 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Helicobacter Pylori Diagnostics sales flourish in Brazil due to the rising investment in advanced technology.
• Argentina Helicobacter Pylori Diagnostics market had a market share of USD 4.97 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The growing investment drives the market growth in the nation.
• Colombia Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 2.63 million in 2024.
• Peru Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 2.43 million in 2024.
• Chile Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 6.2% during the forecast period with a market size of USD 2.13 million in 2024.
• The Rest of Latin America Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 4.76 million in 2024.

Middle East Helicobacter Pylori Diagnostics Market Analysis

According to Cognitive Market Research, the global Helicobacter Pylori Diagnostics market size was estimated at USD 591.5 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 11.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031

• The GCC Countries Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD 5.06 million in 2024. Helicobacter Pylori Diagnostics sales flourish due to the growing investment in healthcare infrastructure.
• The Egypt Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 1.24 million in 2024.
• The South Africa Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1.87 million in 2024. Helicobacter Pylori Diagnostics sales flourish in South Africa due to the rising investment.
• The Turkey Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1.02 million in 2024.
• The Nigeria Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 1.24 million in 2024.
• The Rest of MEA Helicobacter Pylori Diagnostics market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 1.40 million in 2024.

Helicobacter Pylori Diagnostics Market Analysis

Helicobacter Pylori Diagnostics Market Test Type Segment Analysis

According to Cognitive Market Research, Non-Invasive Tests stand out as the dominating category. Due to technological improvements, patient preference for less intrusive procedures, and growing awareness of health risks associated with Helicobacter pylori (H. pylori), the market for non-invasive diagnostic tests for H. pylori is expanding significantly. It's becoming more and more common to use non-invasive testing to confirm the elimination of H. pylori after therapy, as well as for initial diagnosis.

Invasive Tests emerge as the fastest-growing category in the Helicobacter Pylori Diagnostics market. Invasive tests are crucial for verifying H. pylori infections and evaluating associated stomach disorders because they offer excellent diagnostic accuracy and comprehensive information.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Helicobacter Pylori Diagnostics Industry. Request a Free Sample PDF!

Helicobacter Pylori Diagnostics Market Size Segment Analysis

According to Cognitive Market Research, the dominating category is Laboratory Based Test. The efficiency and throughput of diagnostic laboratories are increasing due to the development of automated laboratory systems and high-throughput technologies, which are fostering market expansion.

The fastest-growing category in the Helicobacter Pylori Diagnostics market is the Point of Care Test. POC tests have the benefit of quick results, which are essential for prompt diagnosis and therapy. Patients who live in remote places or primary care settings will find this convenience especially helpful.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Helicobacter Pylori Diagnostics End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, the dominating category is Diagnostics Laboratories. The need for precise and reliable laboratory diagnostic tests is still being driven by the global incidence of H. pylori. Moreover, the precision and effectiveness of laboratory-based tests are improved by ongoing developments in diagnostic technology, such as high-throughput systems and molecular techniques like PCR.

The fastest-growing category in the Helicobacter Pylori Diagnostics market is Hospitals. The market for H. pylori diagnostics is anticipated to increase steadily in the hospital segment due to advances in technology, rising infection rates, and the ability to perform extensive diagnostic tests.

• Diagnostics Laboratories
• Hospitals
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion